A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Matlystatin E | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 19.3 and 59, respectively. Synonyms: Matlystatin E1; Pyrazolo(1,2-a)pyridazin-4-ium,8-carboxy-1-(1-(((hexahydro-2-(2-(2-(hydroxyamino)-2-oxoethyl)-1-oxohexyl)-3-pyridazinyl)carbonyl)amino)-2-methylbutyl)-5,6,7,8-tetrahydro-,hydroxide,inner salt; [(3-{6-[{[1-(8-Carboxy-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-9-ium-1-yl)-2-methylbutyl]imino}(hydroxy)methyl]-1,2-diazinane-1-carbonyl}-1-hydroxyheptylidene)amino]oxidanide. CAS No. 140638-26-2. Molecular formula: C26H42N6O6. Mole weight: 534.65. |  |
| Matlystatin F | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 1.82 and 5.1, respectively. Synonyms: Matlystatin F1; Pyrazolo(1,2-a)pyridazin-4-ium,5-carboxy-1-(1-(((hexahydro-2-(2-(2-(hydroyamino)-2-oxoethyl)-1-oxoheptyl)-3-pyridazinyl)carbonyl)amino)-2-methylbutyl)-5,6,7,8-tetrahydro-,hydroxide,inner salt; [(3-{6-[{[1-(5-Carboxy-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-9-ium-1-yl)-2-methylbutyl]imino}(hydroxy)methyl]-1,2-diazinane-1-carbonyl}-1-hydroxyoctylidene)amino]oxidanide. CAS No. 140667-42-1. Molecular formula: C27H44N6O6. Mole weight: 548.68. | |
| matrilysin | Found in rat uterus; at 19 kDa, the smallest member of peptidase family M10 (interstitial collagenase family). Similar in specificity to stromelysin, but more active on azocoll. Group: Enzymes. Synonyms: matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Enzyme Commission Number: EC 3.4.24.23. CAS No. 141256-52-2. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4304; matrilysin; EC 3.4.24.23; 141256-52-2; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Cat No: EXWM-4304. |  |
| Matrilysin (96-107) | Matrilysin (MAT) is a member of the matrix metalloproteinase (MMP) family which is believed to degrade components of the extracellular matrix (ECM) during processes of tissue remodeling. Synonyms: MMP7 (96-107). | |
| Matrine | Matrine (Matridin-15-one) is an alkaloid found in plants from the Sophora genus that can act as a kappa opioid receptor and u-receptor agonist. Matrine has a variety of pharmacological effects, including anti-cancer, anti-oxidative stress, anti-inflammation and anti-apoptosis effects. Matrine is potential in the research of disease like human non-small cell lung cancer, hepatoma, papillary thyroid cancer and acute kidney injury (AKI) [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Natural products. Alternative Names: Matridin-15-one; Vegard; α-Matrine. CAS No. 519-02-8. Pack Sizes: 10 mM * 1 mL; 100 mg; 200 mg; 500 mg. Product ID: HY-N0164. |  |
| Matrine | Matrine. Group: Biochemicals. Alternative Names: Sophoridine. Grades: Plant Grade. CAS No. 519-02-8. Pack Sizes: 20mg. Molecular Formula: C15H24N2O, Molecular Weight: 248.364. US Biological Life Sciences. |  Worldwide |
| Matrine | Matrine. CAS No. 519-02-8. Product ID: 8-05149. Molecular formula: C15H24N2O. Mole weight: 248.37. Properties: anti-cancer therapeutic, κ-opioid and μ-opioid receptor agonism effects. |  |
| matriptase | This trypsin-like integral-membrane serine peptidase has been implicated in breast cancer invasion and metastasis. The enzyme can activate hepatocyte growth factor/scattering factor (HGF/SF) by cleavage of the two-chain form at an Arg residue to give active α- and β-HGF, but It does not activate plasminogen, which shares high homology with HGF.The enzyme can also activate urokinase plasminogen activator (uPA), which initiates the matrix-degrading peptidase cascade. Belongs in peptidase family S1A. Group: Enzymes. Synonyms: serine protease 14; membrane-type serine protease 1; MT-SP1; prostamin; serine protease TADG-15; tumor-associated differentially-expressed gene 15 protein; ST14; breast cancer 80 kDa protease; epithin; serine endopeptidase SNC19. Enzyme Commission Number: EC 3.4.21.109. CAS No. 241475-96-7. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4104; matriptase; EC 3.4.21.109; 241475-96-7; serine protease 14; membrane-type serine protease 1; MT-SP1; prostamin; serine protease TADG-15; tumor-associated differentially-expressed gene 15 protein; ST14; breast cancer 80 kDa protease; epithin; serine endopeptidase SNC19. Cat No: EXWM-4104. | |
| Matriptase-2 from Human, Recombinant | Matriptase-2 (TMPRSS6) is a type II transmembrane serine protease mainly produced by the liver. It acts as a potent negative regulator of hepcidin, a hepatic peptide hormone and integral player in regulating iron homeostasis. Group: Enzymes. Synonyms: Transmembrane protease serine 6; TMPRSS6; Matriptase-2. Enzyme Commission Number: EC 3.4.21.-. Purity: Purified by multi-step chromatography. Matriptase-2. Mole weight: ~84 kDa; a-subunit: ~56kDa; b-subunit: ~28kDa. Activity: ~2.5U/ul. Stability: Stable for at least 6 months when stored at -20°C. Recommended Assay Buffer: 100mM TRIS, pH 9.0, containing 0.5mg/ml BSA. Do not store diluted solutions. Storage: Short Term Storage: -20°C; Long Term Storage: -80°C. Form: Liquid. In 100mM TRIS-HCl, pH 9.0, containing 150 mM sodium chloride and 20% glycerol. Source: Drosophila Schneider 2 (S2) cells. Species: Human. Transmembrane protease serine 6; TMPRSS6; Matriptase-2. Cat No: NATE-0857. | |
| Matriptase-IN-2 | Matriptase-IN-2 (compound 432) is a potent Matriptase inhibitor [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1268874-09-4. Pack Sizes: 5 mg. Product ID: HY-W783268A. | |
| Matrix Metalloproteinase-12, Catalytic Domain human | recombinant, expressed in E. coli, ?95% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| Matrix Metalloproteinase-13 (HisoTag) from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular pr..., a ca2+- and zn2+- binding catalytic domain, a hinge region, and a c-terminal hemopexin domain. hydrolyzes collagen type ii 5-6 times faster than collagens type i and iii. exhibits high activity towards gelatin and degrades α1-antichymotrypsin and plasminogen activator inhibitor-2. Group: Enzymes. Synonyms: Collagenase-3; Matrix metallopeptidase 13; MMP13; CLG3; MANDP1; MMP-13. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 60 kDa. Activity: >50 mU/mg protein. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: S. frugiperda. Species: Human. Collagenase-3; Matrix metallopeptidase 13; MMP13; CLG3; MANDP1; MMP-13. Cat No: NATE-0859. | |
| Matrix Metalloproteinase-1 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe...may also undergo autocatalysis to yield a 27 kda/22 kda active enzyme. expressed by a large number of cell types. cleaves fibrillar type i collagen. must be activated just prior to use. Group: Enzymes. Synonyms: Matrix Metalloproteinase 1; Human Interstitial Collagenase; Collagenase-1; EC 3.4.24.7; vertebrate collagenase. Enzyme Commission Number: EC 3.4.24.7. CAS No. 9001-12-1. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 56 kDa/52 kDa. Activity: >15 mU/mg protein. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: Human Rheumatoid Synovial Fibroblast. Species: Human. Matrix Metalloproteinase 1; Human Interstitial Collagenase; Collagenase | |
| Matrix Metalloproteinase-1 human | recombinant, expressed in NSO cells, >95% (SDS-PAGE), buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-2 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe... does not interfere with activation. may contain up to 10% timp proteins. during storage, a small portion (less than 10%) of the enzyme may also become activated. Group: Enzymes. Synonyms: 72 kDa Gelatinase; Matrix Metalloproteinase 2; Gelatinase A; EC 3.4.24.24; type IV collagenase; 3/4 collagenase; matrix metalloproteinase 5; 72 kDa gelatinase type A; collagenase IV; collagenase type IV; MMP 2; type IV collagen metalloproteinase; type IV collagenase/gelatinase. Enzyme Commission Number: EC 3.4.24.24. CAS No. 146480-35-5. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 72 kDa. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: CHO Cells. Spe | |
| Matrix Metalloproteinase-2 from mouse | recombinant, expressed in NSO cells, >95% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-2 human | >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-3 from Human, Recombinant | Matrix metalloproteinase-3 (MMP-3) also known as stromelysin-1 and transin (EC 3.4.24.17) cleaves a number of substrates including cartilage proteoglycan, collagen types II, III, IV, V and IX, fibronectin, laminin, and can activate MMP 1. MMP-3 is secreted as 57 and 59 kDa proenzymes and can be activated in vitro by organomercurials (e.g., 4 aminophenylmercuric acetate, APMA) and in vivo by proteases via intermediate forms to a 45 kDa active MMP 3 enzyme. Further autolysis to a 28 kDa form can also occur. MMP-3 is thought to play an important role in pathophysiological degradation processes associated with conditions such as rheumatoid arthritis and cancer cell invas...C 3.4.24.17; matrix metalloproteinase 3; proteoglycanase; collagenase activating protein; procollagenase activator; transin; MMP-3; neutral proteoglycanase; stromelysin; collagen-activating protein. Enzyme Commission Number: EC 3.4.24.17. CAS No. 79955-99-0. Purity: >95% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 57 kDa. Storage: < -70°C; Avoid freeze/thaw. Form: Lyophilized from 100 mM NaCl, 50 mM HEPES, pH 7.3. Species: Human. Stromelysin 1; EC 3.4.24.17; matrix metalloproteinase 3; proteoglycanase; collagenase activating protein; procollagenase activator; transin; MMP-3; neutral proteoglycanase; stromelysin; collagen-activating protein. Cat No: NATE-0861. | |
| Matrix Metalloproteinase-7 from human, Recombinant | MMP-7 degrades general matrix components and may have a role in processes such as host defense, cell proliferation, and protein turnover as well as tissue remodeling. Group: Enzymes. Synonyms: MMP7; matrix metallopeptidase 7; MMP-7; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. CAS No. 141256-52-2. Matrix Metalloproteinase. Storage: -70°C. Form: buffered aqueous solution, Supplied in a buffer containing the active enzyme in 10 mM HEPES, pH 7.4, 0.15 M sodium chloride, 5 mM calcium chloride. Source: E. coli. Species: Human. MMP7; matrix metallopeptidase 7; MMP-7; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Cat No: NATE-0451. | |
| Matrix Metalloproteinase-7 human | ~0.1 mg/mL, recombinant, expressed in E. coli, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-8 from Human, Recombinant | Full-length recombinant human neutrophil pro-collagenase (MMP-8), latent form. Matrix metalloproteinase 8 (MMP-8), or neutrophil collagenase, degrades interstitial collagens, acting preferentially on collagen type I. Increased full-length MMP-8 protein was associated with infiltration into the skin of neutrophils, which are the major cell type that expresses MMP-8. MMP-8 is synthesized and stored in specific granules in neutrophil leukocytes. MMP-8 activity is therefore regulated by factors such as surface-bound ligands (IgG or complement components) that release it through degranulation.Once released and activated through proteolytic or oxidative mechanisms, MMP-8 p...ollagenase activity. Group: Enzymes. Synonyms: Neutrophil collagenase; EC 3.4.24.34; Matrix metalloproteinase-8; MMP-8; PMNL collagenase; PMNL-CL; HNC; CLG1. Enzyme Commission Number: EC 3.4.24.34. CAS No. 9001-12-1. Purity: Greater than 90% as determined by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 75 kDa. Activity: 100 units/ml. Stability: MMP-8 although stable at 4°C for 1 week, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. Appearance: Sterile Filtered clear solution. Source: E. coli. Species: Human. Neutrophil collagenase; EC 3.4.24.34; Matrix metalloproteinase-8; MMP-8; PMNL collagenase; PMNL-CL; HNC; CLG1. Cat No: NATE-0862. | |
| Matrix Metalloproteinase-9 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe...(less than 10%) of the enzyme may also become activated. requires activation prior to use. a simple activation protocol is included. Applications: Immunoblotting (1 ug protein/lane) substrate cleavage assay (1 ug protein/lane) zymography (1 ug protein/lane). Group: Enzymes. Synonyms: Gelatinase B; EC 3.4.24.35; 92-kDa gelatinase; matrix metalloproteinase 9; type V collagenase; 92-kDa type IV collagenase; macrophage gelatinase; 95 kDa type IV collagenase/gelatinase; collagenase IV; collagenase type IV; gelatinase MMP 9; MMP 9; type IV collagen metalloproteinase. Enzyme Commission Number: EC 3.4.24.35. CAS No. 146480-36-6. Purity: >90% by SDS-PAGE. Matrix Metalloprotei | |
| Matrix Metalloproteinase-9 human | recombinant, expressed in, >90% (SDS-PAGE), buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix protein 1 (229-237) | Matrix protein 1 (229-237) is a peptide derived from M1, a matrix protein of the influenza virus. And it is associated with Human respiratory syncytial virus and lung carcinoma. Synonyms: M1 (229-237). | |
| Matrix protein 1 (27-35) | Matrix protein 1 (27-35) is a peptide derived from M1, a matrix protein of the influenza virus. And it is associated with Influenza A virus and lung carcinoma. Synonyms: M1 (27-35). | |
| Matrix protein m1(58-66)(influenza a virus) | Matrix protein m1(58-66)(influenza a virus). Uses: Designed for use in research and industrial production. Additional or Alternative Names: MATRIX PROTEIN M1 (58-66) (INFLUENZA A VIRUS);H-GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU-OH;H2N-GILGFVFTL-OH;GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU;INFLUENZA MATRIX PEPTIDE;INFLUENZA MATRIX PROTEIN M1 (58-66);INFLUENZA VIRUS MATRIX PROTEIN (58-66);GILGFVFTL. Product Category: Heterocyclic Organic Compound. CAS No. 141368-69-6. Molecular formula: C49H75N9O11. Mole weight: 966.17. Purity: 0.96. IUPACName: (2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]. Canonical SMILES: CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)CN. Product ID: ACM141368696. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Matrix Protein M1 (58-66) (Influenza A virus) | It is the epitope of influenza A virus matrix protein. Synonyms: Matrix protein 1 (58-66); FLUM1 A2 peptide (58-66); CEF1, Influenza Matrix Protein M1 58-66; Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu; glycyl-L-isoleucyl-L-leucyl-glycyl-L-phenylalanyl-L-valyl-L-phenylalanyl-L-threonyl-L-leucine. Grades: ≥95%. CAS No. 141368-69-6. Molecular formula: C49H75N9O11. Mole weight: 966.17. | |
| Matrixyl 3000 | Matrixyl 3000 is an anti-aging ingredient developed by Sederma. Matrixyl 3000 is a combination of palmitoyl oligopeptide and palmitoyl tetrapeptide-7. Grades: 98%. | |
| Matrixyl / Palmitoyl Pentapeptide-3/4 (Pal-KTTKS) | Matrixyl / Palmitoyl Pentapeptide-3/4 (Pal-KTTKS). CAS No. 214047-00-4. Product ID: CDC10-0665. Category: Cosmetic Active Peptide. Product Keywords: Cosmetic Ingredients; Active Ingredients; Cosmetic Active Peptide; ; CDC10-0665; Matrixyl / Palmitoyl Pentapeptide-3/4 (Pal-KTTKS); Cosmetic Active Peptide; ; 214047-00-4. Purity: 98%/99%. Applications: For collagen synthesis, repair the damaged skin and anti-aging. |  |
| Mattiflux Flux Powder | Mattiflux Flux Powder. Group: Alloys. |  |
| Maturin | Synonyms: 3-(hydroxymethyl)-9-methoxy-5-methylnaphtho[2,3-b]furan-4-carbaldehyde. Grades: > 95%. CAS No. 62706-43-8. Molecular formula: C16H14O4. Mole weight: 270.28. | |
| Maturinone | Synonyms: 3,5-dimethyl-4H,9H-naphtho[2,3-b]furan-4,9-dione. Grades: > 95%. CAS No. 22985-02-0. Molecular formula: C14H10O3. Mole weight: 226.23. | |
| Maturone | Synonyms: 3-(Hydroxymethyl)-5-methylnaphtho[2,3-b]furan-4,9-dione. Grades: > 95%. CAS No. 29100-83-2. Molecular formula: C14H10O4. Mole weight: 242.23. | |
| Matuzumab | Matuzumab. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Matuzumab;Emd 72000;Emd-72000;Kgaa;Merck kgaa. Product Category: Heterocyclic Organic Compound. CAS No. 339186-68-4. Product ID: ACM339186684. Alfa Chemistry ISO 9001:2015 Certified. | |
| Matuzumab | Matuzumab is a humanized monoclonal antibody that binds to the epidermal growth factor receptor (EGFR). EGFR existing on the surface of normal and tumor cells binds to EGF (epidermal growth factor) and other EGF family growth factors, which leads to the activation of EGFR. Matuzumab is used as an anti-cancer drug. Uses: Anti-cancer drug. Synonyms: Matuzumab; Emd 72000; Emd-72000; Kgaa; Merck kgaa. Grades: 95%. CAS No. 339186-68-4. | |
| Matuzumab | Matuzumab (EMD 72000) is a humanized anti- EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: EMD 72000. CAS No. 339186-68-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9969. | |
| Mauritianin | Mauritianin. Group: Biochemicals. CAS No. 109008-28-8. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Mauritianin | Mauritianin is a kaempferol glycoside isolated from the flowers and leaves of Acalypha indica. Mauritianin is a topoisomerase I inhibitor. Uses: Designed for use in research and industrial production. Product Category: Inhibitors. Appearance: Solid. CAS No. 109008-28-8. Molecular formula: C33H40O19. Mole weight: 740.66. Purity: 0.9953. Canonical SMILES: O=C1C(O[C@H]2[C@@H]([C@H]([C@@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)O2)O)O[C@@]4([H])[C@@H]([C@@H]([C@@H](O)[C@H](C)O4)O)O)=C(C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C61. Product ID: ACM109008288. Alfa Chemistry ISO 9001:2015 Certified. Categories: Mauritians of Indian origin. | |
| Maurocalcine | Maurocalcine is a highly potent cell-penetrating peptide isolated from the Tunisian scorpion Maurus palmatus. It is an activator of Ca2+ release channel and a Ryanodine receptors agonist. It is a 33-mer basic peptide cross-linked by three disulfide bridges. Synonyms: MCa. Grades: >97%. | |
| Maurotoxin | recombinant, expressed in E. coli, ?95% (HPLC), lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Mavacamten | Mavacamten (MYK461) is an orally active modulator of cardiac myosin , with IC 50 s of 490, 711 nM for bovine cardiac and human cardiac, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MYK461; SAR439152. CAS No. 1642288-47-8. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109037. | |
| Mavacoxib | Mavacoxib is a selective, oral long-acting cyclooxygenase-2 (COX-2) inhibitor and a long-acting non-steroidal anti-inflammatory drug (NSAID). Mavacoxib is used to treat pain and inflammation associated with degenerative joint disease in dogs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 170569-88-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-119447. | |
| Mavacoxib | Mavacoxib, a pyrazol derivative, has been found to be a COX-2 Inhibitor that could be used in pain and inflammation therapy for dogs. Synonyms: Mavacoxib; PHA-739521; PHA739521; PHA 739521; PHA 739,521; PHA739,521; PHA-739,521; Mavacoxib. trade name Trocoxil; UNII-YFT7X7SR77; 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide. Grades: 98%. CAS No. 170569-88-7. Molecular formula: C16H11F4N3O2S. Mole weight: 385.34. | |
| Mavacoxib | Mavacoxib. Group: Biochemicals. Alternative Names: 4-[5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; 4-[5-(4-Fluorophenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide; Mavacoxib; PHA 739521; Trocoxil. Grades: Highly Purified. CAS No. 170569-88-7. Pack Sizes: 100mg. Molecular Formula: C16H11F4N3O2S, Molecular Weight: 385.34. US Biological Life Sciences. | Worldwide |
| Mavacoxib-d4 | Mavacoxib-d4. Group: Biochemicals. Alternative Names: 4-[5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide-d4; 4-[5-(4-Fluorophenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide-d4; Mavacoxib-d4; PHA 739521-d4; Trocoxil-d4. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C16H7D4F4N3O2S, Molecular Weight: 389.36. US Biological Life Sciences. | Worldwide |
| Mavatrep | Mavatrep is an orally bioavailable, potent and selective TRPV1 antagonist with Ki value of 6.5 nM, which exhibits minimal effect on the enzymatic activity of CYP isoforms 3A4, 1A2, and 2D6. It antagonizes capsaicin-induced Ca2+ influx, with an IC50 value of 4.6 nM in a TRPV1 functional assay, using cells expressing recombinant human TRPV1 channels. It blocks the activation of hTRPV1 channels by Capsaicin and pH in a concentration-dependent fashion, with IC50 values of 23 and 6.8 nM respectively. It exhibits superior pharmacodynamic properties in the CFA model of inflammatory pain in vivo. It was selected for clinical development for the treatment of pain. It was developed by Johnson & Johnson and now in clinic phase 1 with no progress. Uses: Mavatrep was selected for clinical development for the treatment of pain. Synonyms: JNJ-39439335; JNJ 39439335; JNJ39439335; 2-[2-[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-3H-benzimidazol-5-yl]phenyl]propan-2-ol. Grades: >98 %. CAS No. 956274-94-5. Molecular formula: C25H21F3N2O. Mole weight: 422.44. | |
| Mavoglurant | Mavoglurant is a structurally novel, non-competitive mGlu5 receptor antagonist (IC50=30 nM), as a selective non-competitive antagonist. Synonyms: AFQ056; AFQ-056; AFQ 056; (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester; methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate. Grades: ≥95%. CAS No. 543906-09-8. Molecular formula: C19H23NO3. Mole weight: 313.39. | |
| Mavoglurant | Mavoglurant (AFQ056) is a potent, selective, non-competitive and orally active mGluR5 antagonist, with an IC 50 of 30 nM. Mavoglurant shows a >300 fold selectivity for the mGluR5 over all targets (238) tested. Mavoglurant can be used for the research of Fragile X syndrome (FXS), and L-dopa induced dyskinesias in Parkinson's disease [1] [1] [2]. Mavoglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AFQ056. CAS No. 543906-09-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-15257. | |
| Mavoglurant racemate | Mavoglurant racemate (AFQ-056 racemate) is the racemate of Mavoglurant. Mavoglurant is a novel, non-competitive mGlu5 receptor antagonist [1]. Mavoglurant (racemate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AFQ-056 racemate. CAS No. 1636881-61-2. Pack Sizes: 2 mg; 5 mg. Product ID: HY-15257A. | |
| Mavorixafor free base | Mavorixafor, also known as AMD11070, AMD070, X4P-001, is an orally bioavailable and potent CXCR4 inhibitor. AMD11070 is an antagonist of SDF-1α ligand binding (IC50 = 12.5 ± 1.3 nM), inhibits SDF-1 mediated calcium flux (IC50 = 9.0 ± 2.0 nM) and SDF-1α mediated activation of the CXCR4 receptor as measured by a Eu-GTP binding assay (IC50 =39.8 ± 2.5 nM) or a [(35)S]-GTPγS binding assay (IC50 =19.0 ± 4.1 nM), and inhibits SDF-1α stimulated chemotaxis (IC50 =19.0 ± 4.0 nM). AMD11070 abrogates melanoma cell migration and is significantly more effective than AMD3100. AMD11070 represents a novel therapeutic strategy for both B-RAF wild-type and mutated melanomas. Uses: Designed for use in research and industrial production. Additional or Alternative Names: AMD11070, AMD 11070, AMD-11070, AMD070, AMD 070, AMD-070, X4P-001, X49001, X4P 001, Mavorixafor. Product Category: Antagonists. Appearance: Solid powder. CAS No. 558447-26-0. Molecular formula: C21H27N5. Mole weight: 349.48. Purity: >95%. IUPACName: (S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine. Canonical SMILES: NCCCCN([C@@H]1C2=NC=CC=C2CCC1)CC3=NC4=C(N3)C=CC=C4. Product ID: ACM558447260. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mavorixafor hydrochloride | Mavorixafor (AMD-070) hydrochloride is a potent, selective and orally available CXCR4 antagonist, with an IC 50 value of 13 nM against CXCR4 125 I-SDF binding. Mavorixafor hydrochloride also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC 50 of 1 nM and 9 nM, respectively. Mavorixafor hydrochloride can be used for the study of WHIM syndrome [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AMD-070 hydrochloride; AMD-11070 hydrochloride. CAS No. 880549-30-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-50101C. | |
| Mavrilimumab | Mavrilimumab is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor receptor (GM-CSF-R). Mavrilimumab has been investigated for the treatment of rheumatoid arthritis. Synonyms: CAM 3001; CAM-3001; CAM3001. CAS No. 1085337-57-0. | |
| Mavrilimumab | Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor ( GM-CSF ) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: CAM 3001. CAS No. 1085337-57-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99031. | |
| MAVT | MAVT. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 106241-72-9, 2-Propenoic acid,2-methyl-, 2-(4,6-diamino-1,3,5-triazin-2-yl)ethyl ester, ACMC-1BUX5, AGN-PC-01XBBN, SureCN383376, CTK4A4445, AG-D-20531, 2,4-DIAMINO-6-(METHACRYLOYLOXY)ETHYL-1,3,5-TRIAZINE, 2-(4,6-diamino-1,3,5-triazin-2-yl)ethyl 2-methylprop-2-enoate, 2,4-Diamino-6-[(methacryloyloxy)ethyl]-1,3,5-triazine;2,4-Diamino-6-methacryloyloxyethyl-s-triazine; Curezol MAVT. Product Category: Heterocyclic Organic Compound. CAS No. 106241-72-9. Molecular formula: C9H13N5O2. Mole weight: 223.231820 [g/mol]. Purity: 0.88. IUPACName: 2-(4,6-diamino-1,3,5-triazin-2-yl)ethyl 2-methylprop-2-enoate. Product ID: ACM106241729. Alfa Chemistry ISO 9001:2015 Certified. Categories: MavTV. | |
| MAX-40279 | MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2070931-57-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145723. | |
| Maxacalcitol | Maxacalcitol (22-Oxacalcitriol), a vitamin D3 (HY-15398) analog, is an orally active VDR agonist. Maxacalcitol has a limited calcemic effect. Maxacalcitol has the potential for psoriasis and hyperparathyroidism research [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: 22-Oxacalcitriol. CAS No. 103909-75-7. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-32339. | |
| Maxacalcitol | Maxacalcitol is non-calcemic vitamin D3 analog and ligand of VDR-like receptors. Uses: Dermatologic agents. Synonyms: 22-Oxacalcitriol. Grades: >98%. CAS No. 103909-75-7. Molecular formula: C26H42O4. Mole weight: 418.61. | |
| Maxacalcitol 9-Hydroxy Iso Form | Grades: > 95%. Molecular formula: C26H42O4. Mole weight: 418.6. | |
| Maxacalcitol Impurity B | Synonyms: MC 1292. Grades: > 95%. CAS No. 132071-85-3. Molecular formula: C26H42O4. Mole weight: 418.6. | |
| Maxacalcitol Intermediate | An intermediate of maxacalcitol, which is a derivative of vitamin D3. Maxacalcitol is a potential treatment of secondary hyperparathyroidism. Molecular formula: C38H68O5Si2. Mole weight: 661.127. | |
| Maxacalcitol Preform | Grades: > 95%. Molecular formula: C26H42O4. Mole weight: 418.6. | |
| Maxadilan | Maxadilan, a potent vasodilator isolated from the salivary glands of the sand fly Lutzomyia longipalpis, specifically and effectively activates the mammalian PAC1 receptor, one of the three receptors of PACAP. Synonyms: H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Leu-Gln-Thr-Ser-Val-Gln-Thr-Thr-Ala-Thr-Phe-Thr-Ser-Met-Asp-Thr-Ser-Gln-Leu-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-NH2 (Disulfide bridge: Cys1-Cys5, Cys14-Cys51); Maxadilan (Lutzomyialongipalpis); L-cysteinyl-L-alpha-aspartyl-L-alanyl-L-threonyl-L-cysteinyl-L-glutaminyl-L-phenylalanyl-L-arginyl-L-lysyl-L-alanyl-L-isoleucyl-L-alpha-aspartyl-L-alpha-aspartyl-L-cysteinyl-L-glutaminyl-L-lysyl-L-glutaminyl-L-alanyl-L-histidyl-L-histidyl-L-seryl-L-asparagyl-L-valyl-L-leucyl-L-glutaminyl-L-threonyl-L-seryl-L-valyl-L-glutaminyl-L-threonyl-L-threonyl-L-alanyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-methionyl-L-alpha-aspartyl-L-threonyl-L-seryl-L-glutaminyl-L-leucyl-L-prolyl-glycyl-L-asparagyl-L-seryl-L-valyl-L-phenylalanyl-L-lysyl-L-alpha-glutamyl-L-cysteinyl-L-methionyl-L-lysyl-L-glutaminyl-L-lysyl-L-lysyl-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-lysyl-L-alaninamide (1->5),(14->51)-bis(disulfide). Grades: 95%. CAS No. 135374-80-0. Molecular formula: C291H466N86O94S6. Mole weight: 6865.82. | |
| MAX dimerization protein 1 (MAD) human | recombinant, expressed in E. coli, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| Maximin 1 | Maximin 1 has antibacterial, antifungal, antiviral activity. The source of Maximin 1 is Chinese red belly toad, Bombina maxima, Yunnan, China, Asia. It is active against E. coli ATCC25922, S. aureus ATCC2592, B. pyocyaneus CMCCB10104, B. megatherium, B. dysenterium, K. pneumoniae, and C. albicans ATCC2002 (MIC 3-20 μM). It also has spermicidal effect. Grades: >95% by HPLC. Molecular formula: C120H209N33O35. Mole weight: 2674.14. | |
| Maximin-11 | Maximin-11 is from Bombina maxima and it shows antimicrobial activity against bacteria and against the fungus C.albicans. It has little hemolytic activity. Synonyms: Maximin-11 antimicrobial peptide. | |
| Maximin 15 | Maximin 15 has antibacterial and antifungal activities. The source of Maximin 15 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 2 | Maximin 2 has antibacterial and antifungal activities. The source of Maximin 2 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 28 | Maximin 28 has antibacterial and antifungal activities. The source of Maximin 28 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 3 | Maximin 3 shows antibacterial activity against both Gram-positive and Gram-negative bacteria. It also shows antimicrobial activity against the fungus C.albicans, but not against A.flavus nor P.uticale. It has little hemolytic activity. Maximin 3 possesses a significant cytotoxicity against tumor cell lines and possesses a significant anti-HIV activity. It also shows high spermicidal activity. | |
| Maximin 31 | Maximin 31 has antibacterial and antifungal activities. The source of Maximin 31 is Bombina maxima [Giant fire-bellied toad]. | |
Our database is helping our users find suppliers everyday.
